Jimmy Moses Tindamanyire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jimmy Moses Tindamanyire has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Abubakar Sadik Mustafa
Department of Plant Sciences, Microbiology and Biotechnology, College of Natural Sciences, Makerere University
3 shared publicationsFrank Kalungi
National Agricultural Research Laboratories, National Agricultural Research Organisation
3 shared publicationsJerome Kubiriba
National Agricultural Research Laboratories, National Agricultural Research Organisation
3 shared publicationsAlex Barekye
National Agricultural Research Laboratories, National Agricultural Research Organisation
2 shared publicationsJulius Mulindwa
Department of Biochemistry and Systems Biology, College of Natural Sciences, Makerere University
2 shared publicationsPriver Bwesigye Namanya
National Agricultural Research Laboratories, National Agricultural Research Organisation
2 shared publications
Latest Publications
- Open Access
- 29 January 2026
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 17
Correction: Efficient CRISPR/Cas9-mediated genome editing of phytoene desaturase in Musa-AAA: a critical step for genetic improvement of East African highland bananas
- 29 January 2026
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 17
Open AccessCorrection: Efficient CRISPR/Cas9-mediated genome editing of phytoene desaturase in Musa-AAA: a critical step for genetic improvement of East African highland bananas
- Open Access
- 11 December 2025
- Published by Springer Nature in Vegetos
- p. 1-10
Plant molecular pharming in Africa for sustainable health and economic development
Plant genetic engineering goes back to over 40 years ago with the first genetically modified tobacco expressing the nopaline synthase gene. Since then, genetic engineering has emerged as an important technology as various sectors have included it in their strategic plans with potential impact on healthcare, agriculture and industry. One important aspect is the engineering of plants as bioreactors for production of vaccines, monoclonal antibodies, pesticides, orphan drugs, dyes and many other recombinant novel products. This process is referred to as plant molecular pharming. Plant molecular pharming has numerous benefits over conventional methods such as the use of animal cell lines and prokaryotic systems to produce recombinant products. These benefits include cost effectiveness, rapid and high mass production, easy scalability, accessibility and sustainability. Some African countries such as South Africa have adopted plant molecular pharming and have increased human and infrastructural capacity development, collaborations, and public sensitisation coupled with enabling policies and regulatory frameworks. However, in most of Africa, the sector faces numerous challenges including the lack of funding and expertise, low public acceptance, and poor to inadequate polices and regulatory frameworks. Despite the caveats surrounding the technology, it remains a significantly important tool for addressing global health challenges and fostering biotechnology innovations. Therefore, this review explores plant molecular pharming methods and associated products, advantages, strategies taken to improve the technology, regulatory and social- economic issues surrounding the technology in Africa.
- 11 December 2025
- Published by Springer Nature in Vegetos
- p. 1-10
Open AccessPlant molecular pharming in Africa for sustainable health and economic development
Plant genetic engineering goes back to over 40 years ago with the first genetically modified tobacco expressing the nopaline synthase gene. Since then, genetic engineering has emerged as an important technology as various sectors have included it in their strategic plans with potential impact on healthcare, agriculture and industry. One important aspect is the engineering of plants as bioreactors for production of vaccines, monoclonal antibodies, pesticides, orphan drugs, dyes and many other recombinant novel products. This process is referred to as plant molecular pharming. Plant molecular pharming has numerous benefits over conventional methods such as the use of animal cell lines and prokaryotic systems to produce recombinant products. These benefits include cost effectiveness, rapid and high mass production, easy scalability, accessibility and sustainability. Some African countries such as South Africa have adopted plant molecular pharming and have increased human and infrastructural capacity development, collaborations, and public sensitisation coupled with enabling policies and regulatory frameworks. However, in most of Africa, the sector faces numerous challenges including the lack of funding and expertise, low public acceptance, and poor to inadequate polices and regulatory frameworks. Despite the caveats surrounding the technology, it remains a significantly important tool for addressing global health challenges and fostering biotechnology innovations. Therefore, this review explores plant molecular pharming methods and associated products, advantages, strategies taken to improve the technology, regulatory and social- economic issues surrounding the technology in Africa.
- Open Access
- 16 September 2025
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 16, 1677409
Efficient CRISPR/Cas9-mediated genome editing of phytoene desaturase in Musa-AAA: a critical step for genetic improvement of east African highland bananas
East African highland bananas (EAHBs), locally referred to as “matooke”, are an important staple crop in Uganda. The EAHBs have a triploid genome (AAA) with a large phenotypic diversity in the Great Lakes region of Africa and are challenged by both abiotic and biotic factors. The EAHBs have been improved through conventional breeding and genetic engineering though facing challenges such as genetic drag of unfavorable traits and complex regulatory processes, respectively. Therefore, a more precise approach for crop improvement such as genome editing is highly recommended. In the current study, we assessed the feasibility and applicability of the CRISPR/ Cas 9 mediated-genome editing in EAHBs. Two sgRNAs were designed from the Nakitembe phytoene desaturase ( PDS ) gene and used to edit the PDS gene in Nakitembe (NKT) and NAROBan5 (M30) cultivars. A total of 47 NKT and 130 M30 events were regenerated via agrobacterium -mediated transformation of banana embryogenic cell suspensions. Up to 100% and 94.6% albinism rates were observed in Nakitembe and M30 cultivars respectively with additional albino-variegated and variegated phenotypes observed in M30 only. Carotenoid analysis revealed a significant reduction of total carotenoid content in edited events with all complete albinos showing no detectable carotenoids implying that the carotenoid biosynthetic pathway was effectively disrupted. Sequence analysis revealed that all of the edited events had frameshift mutations leading to PDS disruption. Overall, this study presents the first report of CRISPR/ Cas 9 genome editing in EAHBs and more interestingly on a hybrid, M30 showing high precision and efficiency. This validated genome editing system provides a robust platform for targeted EAHB improvement.
- 16 September 2025
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 16, 1677409
Open AccessEfficient CRISPR/Cas9-mediated genome editing of phytoene desaturase in Musa-AAA: a critical step for genetic improvement of east African highland bananas
East African highland bananas (EAHBs), locally referred to as “matooke”, are an important staple crop in Uganda. The EAHBs have a triploid genome (AAA) with a large phenotypic diversity in the Great Lakes region of Africa and are challenged by both abiotic and biotic factors. The EAHBs have been improved through conventional breeding and genetic engineering though facing challenges such as genetic drag of unfavorable traits and complex regulatory processes, respectively. Therefore, a more precise approach for crop improvement such as genome editing is highly recommended. In the current study, we assessed the feasibility and applicability of the CRISPR/ Cas 9 mediated-genome editing in EAHBs. Two sgRNAs were designed from the Nakitembe phytoene desaturase ( PDS ) gene and used to edit the PDS gene in Nakitembe (NKT) and NAROBan5 (M30) cultivars. A total of 47 NKT and 130 M30 events were regenerated via agrobacterium -mediated transformation of banana embryogenic cell suspensions. Up to 100% and 94.6% albinism rates were observed in Nakitembe and M30 cultivars respectively with additional albino-variegated and variegated phenotypes observed in M30 only. Carotenoid analysis revealed a significant reduction of total carotenoid content in edited events with all complete albinos showing no detectable carotenoids implying that the carotenoid biosynthetic pathway was effectively disrupted. Sequence analysis revealed that all of the edited events had frameshift mutations leading to PDS disruption. Overall, this study presents the first report of CRISPR/ Cas 9 genome editing in EAHBs and more interestingly on a hybrid, M30 showing high precision and efficiency. This validated genome editing system provides a robust platform for targeted EAHB improvement.
- Open Access
- 10 June 2025
- Published by Wiley in Plant Biotechnology Journal
- Vol. 23 (9) , 3713-3726
Field selection of elite events of East African highland bananas expressing elevated levels of pro‐vitamin A
Summary: Biofortification of staple crops is a sustainable strategy to deliver essential micronutrients to impoverished populations in developing countries. Banana is a highly valued crop consumed by over 75% of Ugandans. However, the starchy green cooking bananas have very low levels of pro‐vitamin A (PVA) and heavy dietary reliance on them has been associated with vitamin A deficiency (VAD). Two banana cultivars, hybrid M9 and Nakitembe, were selected for PVA biofortification. A phytoene synthase 2a (MtPsy2a) gene was transformed into the selected cultivars under the control of the constitutive maize polyubiquitin1 promoter or the banana fruit‐preferred ACC oxidase (ACO) promoter. Plants were regenerated on selective media and putatively transgenic plants confirmed by PCR. A total of 356 and 162 transgenic events for M9 and Nakitembe, respectively, were planted in a confined field trial (CFT). Transgenic plants were assessed against non‐transformed controls. Selection was based on phenotype, cycle time, yield, β‐carotene equivalents (β‐CE) and transgene copy number. There were no significant variations in cycle time, but some phenotypic differences were observed between transgenic and non‐transgenic controls. Transgenic fruits had yellow to orange fruit pulps, unlike pulp from non‐transgenic controls that were paler. On average, fruit from transgenic M9 and Nakitembe accumulated fourfold and threefold more β‐CE than non‐transgenic controls, respectively. Five elite lines each of M9 and Nakitembe have been selected for national agronomic performance trials that will aid the selection of lead events to be considered for environmental release.
- 10 June 2025
- Published by Wiley in Plant Biotechnology Journal
- Vol. 23 (9) , 3713-3726
Open AccessField selection of elite events of East African highland bananas expressing elevated levels of pro‐vitamin A
Summary: Biofortification of staple crops is a sustainable strategy to deliver essential micronutrients to impoverished populations in developing countries. Banana is a highly valued crop consumed by over 75% of Ugandans. However, the starchy green cooking bananas have very low levels of pro‐vitamin A (PVA) and heavy dietary reliance on them has been associated with vitamin A deficiency (VAD). Two banana cultivars, hybrid M9 and Nakitembe, were selected for PVA biofortification. A phytoene synthase 2a (MtPsy2a) gene was transformed into the selected cultivars under the control of the constitutive maize polyubiquitin1 promoter or the banana fruit‐preferred ACC oxidase (ACO) promoter. Plants were regenerated on selective media and putatively transgenic plants confirmed by PCR. A total of 356 and 162 transgenic events for M9 and Nakitembe, respectively, were planted in a confined field trial (CFT). Transgenic plants were assessed against non‐transformed controls. Selection was based on phenotype, cycle time, yield, β‐carotene equivalents (β‐CE) and transgene copy number. There were no significant variations in cycle time, but some phenotypic differences were observed between transgenic and non‐transgenic controls. Transgenic fruits had yellow to orange fruit pulps, unlike pulp from non‐transgenic controls that were paler. On average, fruit from transgenic M9 and Nakitembe accumulated fourfold and threefold more β‐CE than non‐transgenic controls, respectively. Five elite lines each of M9 and Nakitembe have been selected for national agronomic performance trials that will aid the selection of lead events to be considered for environmental release.
- Open Access
- 1 September 2020
- Published by Elsevier in ISPRS Journal of Photogrammetry and Remote Sensing
- Vol. 167, 85-103
The potential of in-situ hyperspectral remote sensing for differentiating 12 banana genotypes grown in Uganda
- 1 September 2020
- Published by Elsevier in ISPRS Journal of Photogrammetry and Remote Sensing
- Vol. 167, 85-103
Open AccessThe potential of in-situ hyperspectral remote sensing for differentiating 12 banana genotypes grown in Uganda